| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human LRRC40 recombinant protein (Position: R21-D598) was used as the immunogen for the LRRC40 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
LRRC40 Antibody / Leucine rich repeat containing 40 is a anti-LRRC40 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), ELISA with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: LRRC40
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, ELISA
Biological background
LRRC40 has been detected in a variety of tissues, including immune cells, brain, heart, and reproductive tissues. Leucine rich repeat proteins often mediate key developmental processes, including nervous system patterning and immune recognition, making antibodies against these proteins critical tools in functional studies. Recent data suggests LRRC40 may interact with cytoskeletal regulators or molecular motors, positioning it as a possible contributor to cell movement or organelle transport. This potential role has led to interest in using the LRRC40 antibody in immunohistochemistry, flow cytometry, and western blotting to evaluate protein expression in different tissues and disease contexts.
Beyond general protein interaction research, LRRC40 may be relevant in cancer biology. Several high-throughput expression datasets have reported altered LRRC40 mRNA or protein levels in certain malignancies, suggesting it could contribute to tumor progression or serve as a biomarker. Functional exploration using LRRC40 antibody reagents can help determine whether these correlations reflect causal roles or secondary effects. In neuroscience, the LRR protein family has established links to synapse formation and plasticity, raising the possibility that LRRC40 contributes to neural network development. The LRRC40 antibody can support this line of research by enabling the visualization and quantification of protein levels in neuronal systems.
As with other antibodies provided by
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.